Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study

BACKGROUND: Three botulinum neurotoxin type A preparations (incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA) are widely approved in Europe and in the US for the treatment of glabellar frown lines. The purpose of this study was to determine and compare the time to onset and duration o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rappl, Thomas, Parvizi, Daryousch, Friedl, Herwig, Wiedner, Maria, May, Simone, Kranzelbinder, Bettina, Wurzer, Paul, Hellbom, Bengt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789632/
https://www.ncbi.nlm.nih.gov/pubmed/24098087
http://dx.doi.org/10.2147/CCID.S41537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789632/
https://www.ncbi.nlm.nih.gov/pubmed/24098087
http://dx.doi.org/10.2147/CCID.S41537

Ejemplares similares